Patents by Inventor Michael Szardenings

Michael Szardenings has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10400234
    Abstract: A library of replicating entities, each entity comprises a recombinant vector comprising a randomized nucleic acid sequence, having the reading frame structure [NXX]n [CorAA] [NXX]m [NZZ]o, or [NZZ]o [NXX]m [CorAA] [NXX]n. Each NXX is independently a codon encoding for any amino acid except cysteine, CorAA is a codon encoding for cysteine or at least one other amino acid, each NZZ is independently a codon encoding for any amino acid, and n is an integer from 0 to 40, m is an integer from 1 to 20, o is an integer from 1 to 40, and at least 20 percent of CorAA encode for cysteine. The invention further relates to a set of recombinant vectors and to a set of randomized oligonucleotides, each oligonucleotide having said structure, as well as to a method for generating a library of replicating entities and to a method for identifying an amino acid polymer.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: September 3, 2019
    Assignee: Fraunhofer-Gesellschaft zur Foerderung der angewandten Forschung e.V.
    Inventors: Michael Szardenings, Nicolas Delaroque
  • Publication number: 20180340933
    Abstract: The invention relates to a compilation comprising at least five different peptides, each peptide comprising at least one sequence element corresponding to an epitope selected from the group consisting of SEQ ID NO.: 1-354, wherein at least five different epitopes are represented. The invention further relates to an in vitro method for determining a patient's immune status to soybean allergens, to a method for detecting at least one soybean allergen in a substance and to a method for determining the allergenicity of a soybean variety. Additionally, the invention relates to a kit comprising at least one composition containing a compound comprising at least five different sequence elements each corresponding to an epitope selected from the group consisting of SEQ ID NO.: 1-354, wherein at least five different epitopes are represented.
    Type: Application
    Filed: September 8, 2016
    Publication date: November 29, 2018
    Applicant: Fraunhofer-Gesellschaft zur Foerderung der angewan Forschung e.V.
    Inventors: Karolin Kern, Holger Spiegel, Heide Havenith, Michael Szardenings
  • Patent number: 10011825
    Abstract: The invention relates to a method for activating a surface by increasing the hydrophilicity and/or for binding target structures, particularly selected from the group consisting of proteins, cellular proteins, proteins, cells, carbohydrates, peptides and amino acids. It also relates to the use of an oxidoreductase for activating a surface for the mentioned bonds and to corresponding activated surfaces.
    Type: Grant
    Filed: June 14, 2013
    Date of Patent: July 3, 2018
    Assignee: FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER AGNEWANDTEN FORSCHUNG E.V.
    Inventors: Michael Szardenings, Klaus Rischka, Ingo Grunwald, Annika Eisenschmidt
  • Publication number: 20170058276
    Abstract: A library of replicating entities, each entity comprises a recombinant vector comprising a randomized nucleic acid sequence, having the reading frame structure [NXX]n [CorAA] [NXX]m [NZZ]o, or [NZZ]o [NXX]m [CorAA] [NXX]n. Each NXX is independently a codon encoding for any amino acid except cysteine, CorAA is a codon encoding for cysteine or at least one other amino acid, each NZZ is independently a codon encoding for any amino acid, and n is an integer from 0 to 40, m is an integer from 1 to 20, o is an integer from 1 to 40, and at least 20 percent of CorAA encode for cysteine. The invention further relates to a set of recombinant vectors and to a set of randomized oligonucleotides, each oligonucleotide having said structure, as well as to a method for generating a library of replicating entities and to a method for identifying an amino acid polymer.
    Type: Application
    Filed: March 27, 2015
    Publication date: March 2, 2017
    Inventors: Michael Szardenings, Nicolas Delaroque
  • Patent number: 9193986
    Abstract: Method for marking a target structure, comprising the following steps: a) providing a compound V that includes at least one dihydroxy- or trihydroxyphenyl group, b) providing a means for converting the dihydroxy- or trihydroxyphenyl group to a quinone group, c) providing a target structure, d) oxidizing the dihydroxy- or trihydroxyphenyl group of the compound V to the quinone group, and e) contacting the compound V with the target structure, so that a covalent bond can be formed, wherein in step e) the compound V is used in a concentration such that the maximum concentration of dihydroxy-, trihydroxyphenyl groups and quinone groups that are introduced by the compound V is ?500 ?M, preferably ?300 ?M, and more preferably ?100 ?M.
    Type: Grant
    Filed: September 13, 2013
    Date of Patent: November 24, 2015
    Assignee: FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
    Inventors: Michael Szardenings, Ingo Grunwald, Klaus Rischka, Katharina Richter
  • Publication number: 20150159150
    Abstract: The invention relates to a method for activating a surface by increasing the hydrophilicity and/or for binding target structures, particularly selected from the group consisting of proteins, cellular proteins, proteins, cells, carbohydrates, peptides and amino acids. It also relates to the use of an oxidoreductase for activating a surface for the mentioned bonds and to corresponding activated surfaces.
    Type: Application
    Filed: June 14, 2013
    Publication date: June 11, 2015
    Inventors: Michael Szardenings, Klaus Rischka, Ingo Grunwald, Annika Eisenschmidt
  • Publication number: 20140162303
    Abstract: Method for marking a target structure, comprising the following steps: a) providing a compound V that includes at least one dihydroxy- or trihydroxyphenyl group, b) providing a means for converting the dihydroxy- or trihydroxyphenyl group to a quinone group, c) providing a target structure, d) oxidising the dihydroxy- or trihydroxyphenyl group of the compound V to the quinone group, and e) contacting the compound V with the target structure, so that a covalent bond can be formed, wherein in step e) the compound V is used in a concentration such that the maximum concentration of dihydroxy-, trihydroxyphenyl groups and quinone groups that are introduced by the compound V is ?500 ?M, preferably ?300 ?M, and more preferably ?100 ?M.
    Type: Application
    Filed: September 13, 2013
    Publication date: June 12, 2014
    Inventors: Michael Szardenings, Ingo Grunwald, Klaus Rischka, Katharina Richter
  • Patent number: 7662782
    Abstract: The invention relates to methods of treatment comprising administering a compound of the general formula (1): to a patient or a healthy individual.
    Type: Grant
    Filed: December 29, 2005
    Date of Patent: February 16, 2010
    Assignee: Action Pharma A/S
    Inventors: Michael Szardenings, Ruta Muceniece, Ilze Mutule, Felikss Mutulis, Jarl Wikberg
  • Publication number: 20070027086
    Abstract: The invention relates to methods of treatment comprising administering a compound of the general formula (1): to a patient or a healthy individual.
    Type: Application
    Filed: December 29, 2005
    Publication date: February 1, 2007
    Inventors: Michael Szardenings, Ruta Muceniece, Ilze Mutule, Felikss Mutulis, Jarl Wikberg
  • Publication number: 20060132837
    Abstract: A print request is received at a reusable software component of a server and forwarded to a server application. The server application provides in response to the print request print data to the server's reusable software component, which, in turn, sends a second print request and forwards the print data from an interface of the server's reusable software component to the client. The client receives the second print request and print data at an interface of a reusable software component of the client; and forwards the print data to a spool system of the client in response to the second print request.
    Type: Application
    Filed: December 20, 2004
    Publication date: June 22, 2006
    Inventors: Michael Barth, Michael Szardenings
  • Patent number: 7008925
    Abstract: A compound of general formula (1) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are H or methyl, R13, R14, R15 and R16 are H or alkyl, wherein L1 and L2 are linkers selected from single bond, methyl, ethyl, wherein R19, R20 and R21 are H or —CH2X, NT is selected from H, hydroxyl, alkyl, aminoacid, aminoacid analogue, polypeptide and functional group, CT is selected from hydrogen, hydroxyl, alkyl, aminoacid, aminoacid analogue, polypeptide and functional group shows high selectivity and high affinity for MC1-receptors in combination with effective stimulation or inhibiton of cAMP formation in MC1-receptor expressing cells but low affinity for other subtypes of MC-receptors and may be used to treat a wide range of inflammatory conditions. Also disclosed is a DNA molecule and a corresponding vector encoding the compound, a fusion protein comprising a copy of it, a vector comprising DNA encoding the fusion protein, and a pharmaceutical composition comprising the compound.
    Type: Grant
    Filed: May 5, 1999
    Date of Patent: March 7, 2006
    Assignee: Action Pharma A/S
    Inventors: Michael Szardenings, Ruta Muceniece, Ilze Mutule, Felikss Mutulis, Jarl Wikberg
  • Publication number: 20050266044
    Abstract: The invention provides a method for modulating the surface characteristics of a device, which is at least temporarily in contact with, a body fluid and/or a body tissue, which is characterized in that the device is coated at least with a ligand that binds at least one of the body's own molecules, wherein the modulation effect is caused substantially by the body's own molecule. The invention thus relies on an auto-protection principle wherein the patient's own substances are used in order to modulate the surface characteristics. Furthermore devices are disclosed which are capable of presenting a modulated surface.
    Type: Application
    Filed: April 22, 2005
    Publication date: December 1, 2005
    Applicant: BRACHT BETEILIGUNGSGESELLSCHAFT MBH
    Inventor: Michael Szardenings
  • Patent number: 6898794
    Abstract: The present invention relates to improvements for managing remote function calls and other mechanisms for managing the remote invocation and control of programs. A separation of the request-driven communication work from one broad unstructured bulk of work into at least two separate portions of management is proposed: a dispatching portion and one or more connection portions. Connections are not closed but are reused whenever advantageous, which yields better performance. A standardized interface is set up which is able to be used by a plurality of different requester applications. Thus, a way is found to pass a RFC connection from one application to another, and the same RFC connection can be used by totally independent applications.
    Type: Grant
    Filed: August 21, 2001
    Date of Patent: May 24, 2005
    Assignee: International Business Machines Corporation
    Inventors: Dieter Babutzka, Markus Eichelsdoerfer, Michael Szardenings
  • Publication number: 20020073200
    Abstract: The present invention relates to improvements for managing remote function calls and other mechanisms for managing the remote invocation and control of programs. A separation of the request-driven communication work from one broad unstructured bulk of work into at least two separate portions of management is proposed: a dispatching portion and one or more connection portions. Connections are not closed but are reused whenever advantageous, which yields better performance. A standardized interface is set up which is able to be used by a plurality of different requester applications. Thus, a way is found to pass a RFC connection from one application to another, and the same RFC connection can be used by totally independent applications.
    Type: Application
    Filed: August 21, 2001
    Publication date: June 13, 2002
    Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Dieter Babutzka, Markus Eichelsdoerfer, Michael Szardenings
  • Patent number: 5504853
    Abstract: A display tool is used to simplify the display of a plurality of graphical objects on a display screen. The tool allows a user to select from an inventory of fragments which are required to build a figure. These figures can have child and grandchild elements associated with them. Each figure also has a symbol associated with it. On the display device, an overview window is produced on which graphic objects are shown in symbol form. An arbitrary subset of symbols in the overview window is selected by the user and produces a detail window showing graphical objects or symbols corresponding to the subset of symbols in more detail. These graphical objects are displayed using either their fragment form or their symbol form based on a threshold value as to eliminate overcrowding of screen space. Child and grandchild figure can be directly observed in the detail window by zooming into the selected figure.
    Type: Grant
    Filed: August 21, 1992
    Date of Patent: April 2, 1996
    Assignee: International Business Machines Corporation
    Inventors: Adrianus Schuur, Michael Szardenings